Responses
Clinical/translational cancer immunotherapy
Original research
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
Compose a Response to This Article
Other responses
No responses have been published for this article.
